文献速递前列腺癌

临床局限性前列腺癌治疗比较效果综述

Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review.
PubMed 文献 · J Urol · 2020-12-22

该比较效果综述检索2013年至2020年1月的文献,纳入67篇对照研究,评估临床局限性前列腺癌不同疗法的死亡、转移及 harms。结果显示,临床检出患者中根治性前列腺切除术较观察等待降低死亡但增加 harms;主动监测与根治术或外照射加雄激素剥夺的死亡差异小。

要点

  • 临床检出局限性前列腺癌中,根治术较观察等待降低死亡但增加尿路和勃起功能障碍。
  • 主动监测与根治术或外照射加雄激素剥夺相比死亡差异小,但转移略高。
  • 3D适形放疗加雄激素剥夺加低剂量率近距离放疗较单独3D适形放疗加雄激素剥夺小幅降低死亡。

核心结论

  • 临床检出局限性前列腺癌中,根治性前列腺切除术较观察等待降低死亡但增加 harms,获益可能限于年轻及中危患者。
  • 主动监测与根治性前列腺切除术或外照射加雄激素剥夺相比死亡差异小,但转移略高。

研究设计与样本

  • 比较效果综述,检索 bibliographic databases(2013年至2020年1月)、ClinicalTrials.gov 及系统综述。
  • 纳入67篇符合条件的对照研究,死亡和转移结局要求随访≥5年, harms 要求≥1年。

主要发现

  • 临床检出患者中,观察等待较根治性前列腺切除术可能增加死亡和转移,但减少泌尿和勃起功能障碍。
  • 主动监测与根治性前列腺切除术或外照射加雄激素剥夺相比死亡差异小,转移略高。
  • 根治性前列腺切除术的 harms 大于主动监测;外照射加雄激素剥夺与主动监测的 harms 混合。
  • 3D适形放疗加雄激素剥夺加低剂量率近距离放疗较3D适形放疗加雄激素剥夺小幅降低死亡,转移差异小。
  • 较高危疾病中外照射加雄激素剥夺较单独外照射可能小幅降低死亡和转移,但可能增加性 harms。

临床怎么用

  • 临床检出局限性前列腺癌患者选择根治性前列腺切除术时需权衡死亡获益与泌尿及勃起功能 harms。
  • 主动监测可作为前列腺特异性抗原检出局限性前列腺癌的选项,死亡差异小但需关注略高的转移风险。
  • 较高危患者外照射加雄激素剥夺可能小幅降低死亡和转移,但应告知性 harms 增加。

局限性

  • 其他治疗的新数据较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to identify new information evaluating clinically localized prostate cancer therapies. MATERIALS AND METHODS: Bibliographic databases (2013-January 2020), ClinicalTrials.gov and systematic reviews were searched for controlled studies of treatments for clinically localized prostate cancer with duration ≥5 years for mortality and metastases, and ≥1 year for harms. RESULTS: We identified 67 eligible references. Among patients with clinically, rather than prostate specific antigen, detected localized prostate cancer, watchful waiting may increase mortality and metastases but decreases urinary and erectile dysfunction vs radical prostatectomy. Comparative mortality effect may vary by tumor risk and age but not by race, health status, comorbidities or prostate specific antigen. Active monitoring probably results in little to no mortality difference in prostate specific antigen detected localized prostate cancer vs radical prostatectomy or external beam radiation plus androgen deprivation regardless of tumor risk. Metastases were slightly higher with active monitoring. Harms were greater with radical prostatectomy than active monitoring and mixed between external beam radiation plus androgen deprivation vs active monitoring. 3-Dimensional conformal radiation and androgen deprivation plus low dose rate brachytherapy provided small mortality reductions vs 3-dimensional conformal radiation and androgen deprivation but little to no difference on metastases. External beam radiation plus androgen deprivation vs external beam radiation alone may result in small mortality and metastasis reductions in higher risk disease but may increase sexual harms. Few new data exist on other treatments. CONCLUSIONS: Radical prostatectomy reduces mortality vs watchful waiting in clinically detected localized prostate cancer but causes more harms. Effectiveness may be limited to younger men and those with intermediate risk disease. Active monitoring results in little to no mortality difference vs radical prostatectomy or external beam radiation plus androgen deprivation. Few new data exist on other treatments.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Wilt TJ, Ullman KE, Linskens EJ, et al. Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review. J Urol. 2020. PMID: 33350857. doi:10.1097/JU.0000000000001578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。